Literature DB >> 33992727

An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.

Rutger J Maas1, Sanne Gianotten2, Wilbert A G van der Meijden3.   

Abstract

Entities:  

Year:  2021        PMID： 33992727      PMCID： PMC8116318          DOI： 10.1053/j.ajkd.2021.05.003

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  1 in total

1.  Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Larissa Lebedev; Marina Sapojnikov; Alexander Wechsler; Ronen Varadi-Levi; Doron Zamir; Ana Tobar; Nomy Levin-Iaina; Shlomo Fytlovich; Yoram Yagil
Journal:  Am J Kidney Dis       Date:  2021-04-08       Impact factor: 8.860
  1 in total
  18 in total

1.  Glomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series of 29 Cases.

Authors:  Tiffany N Caza; Clarissa A Cassol; Nidia Messias; Andrew Hannoudi; Randy S Haun; Patrick D Walker; Rebecca M May; Regan M Seipp; Elizabeth J Betchick; Hassan Amin; Mandolin S Ziadie; Michael Haderlie; Joy Eduwu-Okwuwa; Irina Vancea; Melvin Seek; Essam B Elashi; Ganesh Shenoy; Sayeed Khalillullah; Jesse A Flaxenburg; John Brandt; Matthew J Diamond; Adam Frome; Eugene H Kim; Gregory Schlessinger; Erlandas Ulozas; Janice L Weatherspoon; Ethan Thomas Hoerschgen; Steven L Fabian; Sung Yong Bae; Bilal Iqbal; Kanwalijit K Chouhan; Zeina Karam; James T Henry; Christopher P Larsen
Journal:  Kidney360       Date:  2021-09-16

2.  New-onset and relapsing glomerular diseases related to COVID-19 vaccination.

Authors:  Fei Liu; Chunyue Feng; Jianhua Mao; Haidong Fu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

3.  A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18.

Authors:  Mohamad Nour Alhosaini
Journal:  Avicenna J Med       Date:  2022-03-10

Review 4.  COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors:  Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

5.  Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Hirotaka Komaba; Takehiko Wada; Masafumi Fukagawa
Journal:  Am J Kidney Dis       Date:  2021-05-20       Impact factor: 8.860

6.  [A case of acute interstitial nephritis following the Pfizer-BioNTech COVID-19 vaccine].

Authors:  José Carlos de la Flor Merino; Tania Linares Gravalos; Marina Alonso-Riaño; Pilar Segura Cebollada; Cristina Albarracin Serra; Elisa Ruiz Cicero; Gioconda Gallegos Bayas; Miguel Rodeles Del Pozo
Journal:  Nefrologia       Date:  2021-06-29       Impact factor: 3.084

7.  Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine.

Authors:  Fumika Tanaka; Kan Katayama; Kensuke Joh; Kayo Tsujimoto; Masahiro Yamawaki; Ryosuke Saiki; Tairo Kurita; Tomohiro Murata; Kaoru Dohi
Journal:  Clin Kidney J       Date:  2021-11-22

8.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

9.  [Kidney damage in COVID-19].

Authors:  Stéphane Burtey; Marion Sallée
Journal:  Nephrol Ther       Date:  2021-06-23       Impact factor: 0.722

10.  Nephrotic Syndrome Following ChAdOx1 nCoV-19 Vaccine Against SARScoV-2.

Authors:  Y J Anupama; Ravi G N Patel; Mahesha Vankalakunti
Journal:  Kidney Int Rep       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.